Final Programme - iuphar

FC17 New approaches and targets in psychiatry
Thu 423 The 5-HT7 receptor mediates fear conditioning through the amygdaloid extracellular signal-regulated
kinase signalling in mice
Minoru Tsuji, (Japan), K Miyagawa, T Takeuchi, H Takeda
Thu 424 Ethic and psychiatry clinical trials’ design
E Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba)
Thu 425 The impact of psychiatry clinical trials over the clinical practice. The Cuban experience
R Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba)
Thu 426 A “two-step” competition binding approach to determine unlabelled ligand-receptor complex dissociation
rates
Georges Vauquelin, (Belgium), M Wennerberg, A Balendran, A Packeu
Thu 427 Peripheral blood mononuclear cell gene expression profiles identify subjects with major depressive
disorder (MDD) among healthy controls
J Vistisen, J Tamm, R Artymyshyn, I Antonijevic, M Das, A Abdourahman, Birgitte Søgaard, (Denmark)
Thu 428 Stereotypy in the deer mouse, correlation with cortico-striatal oxidative status and dopamine turnover,
and response to combined fluoxetine/risperidone treatment
De Wet Wolmarans, (South Africa), M Guldenpfennig, B Harvey, D Stein, J du Preez
Thu 429 Erythropoietin-induced sonic hedgehog expression contributes to brain-derived neurotrophic factormediated
neuroprotection against mitochondrial dysfunction
Ding I Yang, (Taiwan), CL Wu
Thu 430 Gravity-changing stress increases serotonin-related gene expression in the mouse brain
Mitsuhiro Yoshioka, (Japan), T Yamaguchi, H Ohta, J Gyotoku, T Ochiai
Thu 431 Inhibition of acetylcholinesterase activity in a rat model of Wernicke’s encephalopathy: In vivo and in
vitro effects of thiamine
A Zarros, Hussam Al-Humadi, (Greece), C Liapi, M Almpani, V Stolakis, N Skandali, E Katsouni,
S Tsakiris
Thu 432 Discovery and validation of the combinational therapeutic targets for Alzheimer's disease: A preliminary
study
Wenxia Zhou, (PR China), X-R Cheng, N Jiang, Y Zhang
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 311